Burns J M, Hart D M, Hughes R L, Kelman A W, Hillis W S
Department of Materia Medica, Stobhill General Hospital, Glasgow.
Br J Anaesth. 1988 Sep;61(3):345-6. doi: 10.1093/bja/61.3.345.
Cardiac arrhythmias are a well recognized complication of anaesthesia for laparoscopy. The effect of nadolol, given by mouth 12 h before operation, was compared with placebo on arrhythmias in 86 females undergoing laparoscopy. All types of arrhythmia were documented; there was a 97% incidence in the placebo group, but in the nadolol group there was a smaller incidence of supraventricular tachycardia, ventricular ectopics and atrioventricular dissociation (P less than 0.01). There was no significant difference in the incidence of sinus bradycardia. Nadolol may be recommended as a safe agent to be given by mouth before laparoscopy to reduce the frequency of cardiac arrhythmias during anaesthesia.
心律失常是腹腔镜手术麻醉中一种公认的并发症。将术前12小时口服纳多洛尔的效果与安慰剂对86例接受腹腔镜手术的女性心律失常的影响进行了比较。记录了所有类型的心律失常;安慰剂组的发生率为97%,但纳多洛尔组室上性心动过速、室性早搏和房室分离的发生率较低(P<0.01)。窦性心动过缓的发生率没有显著差异。纳多洛尔可作为一种安全的药物推荐在腹腔镜手术前口服,以减少麻醉期间心律失常的发生频率。